All three sickle cell disease participants treated with briquilimab successfully engrafted with neutrophil engraftment within 12-16 days
First two participants with peripheral blood chimerism at 60 days after allogeneic stem cell transplant achieved 100% donor myeloid chimerism
First participant treated has a total hemoglobin level of 13.3 g/dL at five months follow up, increased from 8-9 g/dL at baseline
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.